secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001737287-24-000062
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.05, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allogene Therapeutics amends Code of Business Conduct and Ethics
----------------------------------------------------------------

- Updates insider trading policy, antitrust restrictions, and conflicts-of-interest procedures.
- Expands fair dealing obligations, gift/entertainment restrictions, and data privacy/cybersecurity requirements.
- Adds express requirement to comply with all other Company policies supporting the Code.
- Applies to all directors, officers, employees, and certain consultants/contractors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/0001737287-24-000062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000173728724000062/allo-20241003.htm
  HTML page:      https://secwatch.observer/filing/0001737287-24-000062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer